段立新

段立新 (board member) discloses dealings in 九典制药 to SSE / SZSE (CSRC). We count 2 filings, every one of them for a trade on 17 January 2023.

Sales make up the whole of the open-market record (2 sales, €8.4M).

Most recently, on 17 January 2023, the filings show an open-market sale worth €525k in 九典制药. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.